Price (delayed)
$0.4103
Market cap
$18.14M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.31
Enterprise value
$55.78M
Harvard Bioscience is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its customers range from renowned
There are no recent dividends present for HBIO.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.